about
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerProteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancerApolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomic profiling in ovarian cancer.
@en
Proteomic profiling in ovarian cancer.
@nl
type
label
Proteomic profiling in ovarian cancer.
@en
Proteomic profiling in ovarian cancer.
@nl
prefLabel
Proteomic profiling in ovarian cancer.
@en
Proteomic profiling in ovarian cancer.
@nl
P1476
Proteomic profiling in ovarian cancer.
@en
P2093
Elise C Kohn
Geoffrey Kim
P356
10.1111/IGC.0B013E3181C03929
P478
19 Suppl 2
P50
P577
2009-12-01T00:00:00Z